MYC and lymphoma: However, recent evidence shows that MYC and BCL2 copy number variations do not produce the high-risk gene expression signature seen in most true DH/TH lymphomas harboring MYC and BCL2 rearrangements, suggesting that copy number variations should not be used to expand the definition of DH/TH lymphomas [9].